Rapid Diagnostics Market: Industry Insights and Forecast, 2020-2025: Major Key Players, Opportunities, Trends, and Revenue Analysis

June 2, 2021June 2, 2021 AngelaHooper

The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019–2025. The global rapid diagnostics market is one of the major segments of the global in-vitro diagnostics market. The segment has experienced unprecedented growth after the outbreak of the novel coronavirus. The pandemic, which was initially identified in Wuhan, Hubei Province, China, in December 2019, infected over 35.7 million people, resulting in approximately 1.05 million deaths across the globe till the end of September 2020. In response to the growing COVID-19 pandemic and the shortage of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. These simple test kits are based either on the detection of proteins from the COVID-19 virus in respiratory samples (e.g. sputum, throat swab) or the detection in blood or serum of human antibodies generated in response to the infection.

Request to Fill The Form To get Sample Copy of This Business Report: https://www.sdki.jp/sample-request-92886

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

INSIGHTS BY VENDORS

Abbott, BD, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players that account for significant shares in the rapid diagnostics market.
The global rapid disease diagnostics market is highly dynamic with the presence of several global and local players offering a diverse range of instruments/analyzers and reagents for diagnosing infectious and other diseases. The market is consolidated with global players accounting for dominant shares. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Abbott, F. Hoffmann-La Roche, Danaher, Quidel, Luminex, and BD are continuously focusing on product development and offering new diagnostics technology to increase their market presence.

The following factors are likely to contribute to the growth of the rapid diagnostics market during the forecast period:

• Increased Demand for Rapid COVID-19 Testing
• High Demand for Rapid Molecular Diagnostic Tests
• Growing Prevalence/Incidence of Several Acute & Chronic Diseases

Global Rapid Diagnostics Market Segmentation

The global rapid diagnostics market research report includes a detailed segmentation by product, end-users, application, prescription, geography. In 2019, the blood glucose testing segment accounted for a share of over 61% of the rapid diagnostics market. Point of care testing (POCT) for glucose levels is a common procedure performed several times a day in different medical settings worldwide. POCT glucose devices deliver rapid and relatively precise glucose measurements performed on the blood at patients’ bedsides, thereby offering quick results. New technology is constantly being introduced. Implantable sensor devices for continuous glucose monitoring that last three to seven days have been approved by the FDA and allow for strict glycemic controls with less discomfort for the patient.

In 2019, the consumables segment accounted for a share of over 73%. The increasing share can be attributed to the high usage of a wide array of standard reagents and test kits to perform several tests. The usage of consumables is reoccurring in nature; the consumables segment generates continuous revenue for vendors. Therefore, several renowned vendors are manufacturing consumables required for analyzers.

Request to Fill The Form To get Sample Copy of This Business Report: https://www.sdki.jp/sample-request-92886

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

The blood glucose testing segment is growing at a significant rate. The growth can be attributed to the growing demand for compact and portable benchtop analyzers, handheld analyzers, and professional rapid test kits for diagnosing various acute and chronic diseases in low-resource and ambulatory care settings. Professional healthcare settings, such as physician office labs, clinics, emergency care centers, critical care in hospitals, nursing homes, community care centers, home care centers such as geriatric and pediatric care centers are performing a broad range of POC diagnostic tests for quick diagnosis and deciding on prescribing the appropriate treatment for patients.

In 2019, the home care segment accounted for a share of 51% of the global rapid diagnostic testing market. Home care settings have become popular, and the demand for these settings has been growing across the globe. The demand is extremely high in developed countries. Several factors such as changes in demography and epidemiology have affected the popularity of home settings. A rise in communicable/contagious diseases such as the COVID-19 virus has influenced the demand for home care setting and rapid diagnostics tests for COVID-19. Several lifestyle-related diseases such as diabetes, heart and respiratory diseases, stroke and cancer could be effectively and efficiently taken care of at home with appropriate support. Moreover, changes in social norms, values, and behavior are contributing to the increasing demand for formal home care services.

By Application

• Blood Glucose Testing
• Cardiometabolic Testing
• Infectious Disease Testing
• Blood Coagulation Testing
• Hematology Testing
• Cancer Testing
• Drug Abuse Testing
• Pregnancy & Fertility/Ovulation Testing

By Products

• Consumables
• Analyzers/Instruments

By End-user

• Hospitals & Clinics
• Laboratories
• Individuals/Homecare
• Others

The study considers the present scenario of the rapid diagnostics market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Table of Content

1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Application
4.4.3 Market Segmentation by Prescription
4.4.4 Market Segmentation by End-Users
4.4.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

Request to Fill The Form To get Sample Copy of This Business Report: https://www.sdki.jp/sample-request-92886

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

KEY QUESTIONS ANSWERED

1. What is the rapid diagnostics market size and growth rate during the forecast period?
2. What are the factors affecting the growth of the rapid diagnostics market share?
3. What is the growth of APAC rapid diagnostics market share during the forecast period?
4. Who are the leading vendors in the rapid diagnostics market?

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790